Presented by: Dr Tony Cass, Institute of Biomedical Engineering, Imperial College London
Date and time: Thursday 19 February: 12.30-14.00, War Studies Meeting Room, KCL

The ability to control the properties of materials and devices on length scales between 1 and 100nm forms the emerging discipline of nanotechnology and will revolutionise many areas of human activity over the next few decades. Medicine is one area in particular where the impact of nanotechnology has been identified as being particularly significant as not only will it impact on conventional approaches to diagnosis and treatment (‘smarter’ drug delivery, better imaging agents, advanced diagnostics) but also enhances new medical strategies (genetic and cell therapies). One of the factors in determining both the technical feasibility and social acceptance of nanomedicine is an understanding of what timescales apply to the different applications and this will form the basis of the seminar.